Physician
Hematology
Dr. Ken H. Young, MD
|
|
Give Review
Young is an expert in the field of Hematology. He studied medicine at University of Nebraska Medical Center. University of Nebraska Medical Center is a one of the best medicals schools. University of Nebraska Medical Center is ranked 60 in research and 4 in primary care medicine Young is a published doctor. He published 37 publications, including: 'Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.' Doctor Ken H. Young, MD accepts Medicare.
Publications
- Crystal-storing histiocytosis: a clinicopathological study of 13 cases.
- Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
- Stratifying diffuse large B-cell Lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.
- Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell Lymphoma patients treated with rituxim...
- Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell Lymphoma.
- Mutational profiling of therapy-related myelodysplastic syndromes and Acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
- CD5-positive follicular Lymphoma: clinicopathologic correlations and outcome in 88 cases.
- A microRNA signature profile in EBV+ diffuse large B-cell Lymphoma of the elderly.
- Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma.
- Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple Myeloma.
- Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin Lymphoma.
- CD30 diagnostics and testing.
- Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation.
- The dichotomy of p53 regulation by noncoding RNAs.
- NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell Lymphoma.
- Atypical chronic myeloid Leukemia (aCML) BCR-ABL1-negative is clinicopathologically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms (MDS/MPN-...
- Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell Lymphoma (DLBCL) treated with immunochemotherapy: A report from the International ...
- Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries.
- Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients.
- Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic Acute myeloid leukemia.
- Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell Lymphoma patients treated with rituximab-CHOP.
- Haematological cancer: Richter's transformation in CLL-a distinct Lymphoma.
- Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell Lymphomas.
- MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma.
- Recent advances in de novo CD5(+) Diffuse Large B cell Lymphoma (DLBCL).
- Clonally related composite follicular Lymphoma and mantle cell Lymphoma with clinicopathologic features and biological implications.
- Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed Lymphoma: a phase II clinical trial.
- MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell Lymphoma patients treated with rituximab-CHOP immunochemotherapy.
- Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell Lymphoma treated with rituximab-CHOP: a report from the International DLBCL Ritu...
- MYC/BCL2 protein co-expression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell Lymphoma and demonstrates high-risk gene expres...
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell Lymphoma: an international collaborative study.
- Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic Cell neoplasm: case report and literature review.
- EBV-driven B-Cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.
- Epstein-Barr virus-positive T/NK-Cell lymphoproliferative disorders.
- LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
- Dyspoietic changes associated with hepatosplenic T-cell Lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
Schools
Med Fakulteten U Lund
Or Health Science University
University Ne Med Center
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Deep Vein Thrombosis (DVT)
- View All
Doctors Specialties
- Hematology
- Hematopathology
Accepted Insurances
- American Enterprise Group
- American Republic
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- GEHA
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Nebraska Medical Center -
Oregon Health & Science University -
Zhejiang Medical University
Helpful Reviews
Similar Doctors
|
Dr. Sahba Q. Nadeem, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick H. Archie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Uday R. Popat, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Jorge R. Quesada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naveen Pemmaraju, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jerome B. Bart, MD |
|
|
Dr. Sanam Loghavi, MD |
|
|
Dr. Mohamed T. Elghetany, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annisa L. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis E. Fayad, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark A. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wei Lin, MD |
|
|
Dr. Musa Yilmaz, MD
This Doctor is OpenDoctor Recommended.
|